Efficacy of autologous bone marrow mononuclear cell therapy in patients with peripheral arterial disease

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 11, 2014, Pages 1183-1196

  Wang, Zheng Xu ^a   Li, Duo ^a   Cao, Jun Xia ^a   Liu, Yi Shan ^a   Wang, Min ^a   Zhang, Xiao Yan ^a   Li, Jun Li ^a   Wang, Hai Bo ^a   Liu, Jin Long ^a   Xu, Bei Lei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Autologous bone marrow cell; Meta analysis; Peripheral arterial disease; Stem cell

Indexed keywords

AMPUTATION; ANKLE BRACHIAL INDEX; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW DERIVED MONONUCLEAR CELL; CLINICAL TRIAL (TOPIC); CRITICAL LIMB ISCHEMIA; HUMAN; INFORMATION PROCESSING; META ANALYSIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL; TRANSCUTANEOUS OXYGEN MONITORING; VISUAL ANALOG SCALE; AUTOTRANSPLANTATION; BIOLOGICAL THERAPY; BONE MARROW TRANSPLANTATION; META ANALYSIS (TOPIC); PERIPHERAL ARTERIAL DISEASE; PROGNOSIS;

BONE MARROW TRANSPLANTATION; CELL- AND TISSUE-BASED THERAPY; CLINICAL TRIALS AS TOPIC; HUMANS; META-ANALYSIS AS TOPIC; PERIPHERAL ARTERIAL DISEASE; PROGNOSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 84911928728     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.23374     Document Type: Article

References (49)

1. Gian PF, Carlo A, Angelo A: Autologous stem cell therapy for peripheral arterial disease Meta-analysis and systematic review of the literature. Atherosclerosis, 2010; 209: 10-17
2. Mamidi MK, Pal R, Dey S, Bin Abdullah BJ, Zakaria Z, Rao MS, Das AK: Cell therapy in critical limb ischemia: current developments and future progress. Cytotherapy, 2012; 14: 902-916
3. Ozkan U, Oguzkurt L, Tercan F: Atherosclerotic risk factors and segmental distribution in symptomtic peripheral artery disease. J Vasc Interv Radiol, 2009; 20: 437-441
4. Tepper OM, Capla JM, Galiano RD, Ceradini DJ, Callaghan MJ, Kleinman ME, Gurtner GC: Adult vasculo-genesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood, 2005; 105: 1068-1077
5. Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, Holstein P, Jude E, Jirkovska A, Mauri-cio D, Piaggesi A, Reike H, Spraul M, Van Acker K, Van Baal S, Van Merode F, Uccioli L, Urbancic V, Ragnarson Tennvall G: Resource utilisation and costs associated with the treatment of diabetic foot ulcers: Prospective data from the Eurodiale Study. Diabetologia, 2008; 51: 1826-1834
6. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshi-moto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T: Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet, 2002; 360: 427-435
7. Liew A, O'Brien T: Therapeutic potential for mesenchy-mal stem cell transplantation in critical limb ischemia. Stem Cell Res Ther, 2012; 3: 28
8. Amann B, Ludemann C, Ruckert R, Lawall H, Liesenfeld B, Schneider M, Schmidt-Lucke J: Design and rationale of a randomized, double-blind, placebo-controlled phase m study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI). Vasa, 2008; 37: 319-325
9. Miyamoto K, Nishigami K, Nagaya N, Akutsu K, Chiku M, Kamei M, Soma T, Miyata S, Higashi M, Tanaka R, Nakatani T, Nonogi H, Takeshita S: Unblinded Pilot Study of Autologous Transplantation of Bone Marrow Mononuclear Cells in Patients With Thromboangiitis Obliterans. Circulation, 2006; 114: 2679-2684
10. De Vriese AS, Billiet J, Van Droogenbroeck J, Ghekiere J, De Letter JA: Autologous transplantation of bone marrow mononuclear cells for limb ischemia in a caucasian population with atherosclerosis obliterans. J Intern Med, 2008; 263: 395-403
11. Durdu S, Akar AR, Arat M, Sancak T, Eren NT, Ozy-urda U: Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-IE thromboangiitis obliterans. J Vasc Surg, 2006; 44: 732-739
12. Saigawa T, Kato K, Ozawa T, Toba K, Makiyama Y, Mina-gawa S, Hashimoto S, Furukawa T, Nakamura Y, Hanawa H, Kodama M, Yoshimura N, Fujiwara H, Namura O, Sogawa M, Hayashi J, Aizawa Y: Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J, 2004; 68: 1189-1193
13. Motukuru V, Suresh KR, Vivekanand V, Raj S, Girija KR: Therapeutic angiogenesis in Buerger's disease (thrombo-angiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells. J Vasc Surg, 2008; 48: 53S-60S; discussion 60S
14. Cobellis G, Silvestroni A, Lillo S, Sica G, Botti C, Maione Schiavone V, Rocco S, Brando G, Sica V: Long-term effects of repeated autologous transplantation of bone marrow cells in patients affected by peripheral arterial disease. Bone Marrow Transplant, 2008; 42: 667-672
15. Barć P, Skóra J, Pupka A, Turkiewicz D, Dorobisz AT, Garcarek J, Tomasiewicz, B, Szyber, P: Bone-marrow cells in therapy of critical limb ischaemia of lower extremities — own experience. Acta Angiol, 2006; 12: 155-166
16. Schiavetta A, Maione C, Botti C, Marino G, Lillo S, Gar-rone A, Lanza L, Pagliari S, Silvestroni A, Signoriello G, Sica V, Cobellis G: A phase I trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure Evaluation of Stem Cells study. Stem Cells Transl Med, 2012; 1: 572-578
17. Klepanec A, Mistrik M, Altaner C, Valachovicova M, Olejarova I, Slysko R, Balazs T, Urlandova T, Hladikova Liska B, Tomka J, Vulev I, Madaric J: No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia. Cell Transplant, 2012; 21: 1909-1918
18. Amann B, Luedemann C, Ratei R, Schmidt-Lucke JA: Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant, 2009; 18: 371-380
19. Benoit E, O'Donnell TF Jr, Iafrati MD, Asher E, Bandyk DF, Hallett JW, Lumsden AB, Pearl GJ, Roddy SP, Vijayaraghavan K, Patel AN: The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design. J Transl Med, 2011; 9: 165
20. Chen LZ, Chen CY, Xiao TH: Observation on therapeutic effect of autologous bone marrow stem cell transplantation for diabetes patients complicated with lower limb ischemia. Chinese Nursing Research, 2005; 19: 1005-1006
21. Chen B, Lu DB, Liang ZW, Jiang YZ, Wang FH, Wu QN, Zhang ZH: Autologous bone marrow mesenchymal stem cell transplantation for treatment of diabetic foot following amplification in vitro. Journal of clinical reha-bilitive tissue engineering research, 2009; 13: 6227-6230
22. Lu D, Chen B, Liang Z, Deng W, Jiang Y, Li S, Xu J, Wu Q, Zhang Z, Xie B, Chen S: Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract, 2011; 92: 26-36
23. Walter DH, Krankenberg H, Balzer JO, Kalka C, Baumgartner I, Schluter M, Tonn T, Seeger F, Dimmeler S, Lindhoff-Last E, Zeiher AM; PROVASA Investigators: Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circ Cardiovasc Interv, 2014; 4: 26-37
24. Perin EC, Silva G, Gahremanpour A, Canales J, Zheng Y, Cabreira-Hansen MG, Mendelsohn F, Chronos N, Haley R, Willerson JT, Annex BH: A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia. Catheter Cardiovasc Interv, 2011; 78: 1060-1067
25. Gan Y, Zheng CH, Chen J, Jia P, Guo ZZ, Zhang JB, Li TN, Yu LL: Autologous bone marrow stem cell transplantation for severe chronic lower limb ischemia in 15 cases. Journal of clinical rehabilitative tissue engineering research, 2008; 12: 1541-1544
26. Liu GL, Li WJ, Yu F, Xiang XX, Zhang HQ, Xiao HZ, Liu XL: Autologous bone marrow stem cell transplantation for treatment of diabetic patients with lower limb ischemic disease reported 20 cases. Bulletin of the Academy of Military Medical Sciences, 2007; 31: 196-197
27. Iafrati MD, Hallett JW, Geils G, Pearl G, Lumsden A, Peden E, Bandyk D, Vijayaraghava KS, Radhakrishnan R, Ascher E, Hingorani A, Roddy S: Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia. J Vasc Surg, 2011; 54: 1650-1658
28. Bartsch T, Brehm M, Zeus T, Kogler G, Wernet P, Strauer BE: Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study). Clin Res Cardiol, 2007; 96: 891-899
29. Prochazka V, Gumulec J, Jaluvka F, Salounova D, Jonszta T, Czerny D, Krajća J, Urbanec R, Klement P, Martinek J, Klement GL: Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant, 2010; 19: 1413-1424
30. Wang GY, Zhu LY, Hou RR, Ma LC, Hu LY, Li XL, Yang SL, Shan W: Autologous transplantation of bone-marrow mononuclear cells for treatment of diabetic lower limb ischemia in 83 cases. Journal of Clinical Rehabilitative Tissue Engineering Research, 2011; 15: 2508-2511
31. Wang W, Liu CJ, Qiao T, Liu C, Huang D: Autologous bone marrow mononuclear cells transplantation in treatment of severe lower limb ischemia in 56 cases in the same institute: One-year follow up. Journal of Clinical Rehabilitative Tissue Engineering Research, 2010; 14: 85128515
32. Wang XH, Wang YL, Wang GY, Zhu LY, Hou RR, Ma LC, Hu LY, Li XL, Yang XL, Yang SL, Dan W: Autologous bone marrow mesenchymal stem cell transplantation for treatment Clinical analysis of 69 cases of diabetic foot. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2011; 20: 3936-3937
33. Xin SJ, Song QB, Hu HD, Zhang J, Qin LF, Zhang ZS, Zhang P, Luo YW, Ding K, Duan ZQ: Autologous transplantation of bone marrow mononuclear cell in treating severe chronic lower extremity ischemia: a report of 42 cases. Journal of China Medical University, 2006; 6: 627-630
34. Xu YF, Yang XF, Wu YX, Wang HM, Zhang YB, Xu B, Lu X, Zhang Y: Effect of autologous bone marrow stem cell transplantation on ischemic disease of lower extremity: Evaluation on the effect of 43 cases after 6 months. Journal of Clinical Rehabilitative Tissue Engineering Research, 2007; 11: 534-535
35. Yi H, Zhang L, Wang R, Shu Y: Clinical study of autolo-gous bone marrow disease and chronic lower limb ischemia mononuclear cell transplantation therapy. Journal of Clinical Medicine in Practice, 2011; 15: 31-33
36. Saito Y, Sasaki K, Katsuda Y, Murohara T, Takeshita Y, Okazaki T, Arima K, Katsuki Y, Shintani S, Shimada T, Akashi H, Ikeda H, Imaizumi T: Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease. Circ J, 2007; 71: 1187-1192
37. Idei N, Soga J, Hata T, Fujii Y, Fujimura N, Mikami S, Maruhashi T, Nishioka K, Hidaka T, Kihara Y, Chowd-hury M, Noma K, Taguchi A, Chayama K, Sueda T, Higashi Y: Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease. Circ Cardiovasc Interv, 2011; 4: 15-25
38. Powell RJ, Comerota AJ, Berceli SA, Guzman R, Henry TD, Tzeng E, Velazquez O, Marston WA, Bartel RL, Longcore A, Stern T, Watling S: Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia. J Vasc Surg, 2011; 54: 1032-1041
39. Chung J, Timaran DA, Modrall JG, Ahn C, Timaran CH, Kirkwood ML, Baig MS, Valentine RJ: Optimal medical therapy predicts amputationn-free survival in chronic critical limb ischemia. J Vasc Surg, 2013; 58: 972-980
40. Larrivee B, Karsan A: Involvement of marrow-derived endothelial cells in vascularization. Handb Exp Pharmacol, 2007; 180: 89-114
41. Gremmels H, Fledderus JO, Teraa M, Verhaar MC: Mes-enchymal stromal cells for the treatment of critical limb ischemia: context and perspective. Stem Cell Res Ther, 2013; 4: 140
42. Descamps B, Emanueli C: Vascular differentiation from embryonic stem cells: novel technologies and therapeutic promises. Vascul Pharmacol, 2012; 56: 267-279
43. Silvestre JS, Smadja DM, Levy BI: Postischemic revascu-larization: from cellular and molecular mechanisms to clinical applications. Physiol Rev, 2013; 93: 1743-1802
44. Watt SM, Gullo F, van der Garde M, Markeson D, Camicia R, Khoo CP, Zwaginga JJ: The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential. Br Med Bull, 2013; 108: 25-53
45. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S: Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood, 2000; 95: 952-958
46. Li TS, Hamano K, Nishida M, Hayashi M, Ito H, Mikamo A, Matsuzaki M: CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am J Physiol Heart Circ Physiol, 2003; 285: H931-H937
47. Benoit E, O'Donnell TF, Patel AN: Safety and efficacy of autologous cell therapy in critical limb ischemia: a systematic review. Cell Transplant, 2013; 22: 545-562
48. Liu FP, Dong JJ, Sun SJ, Gao WY, Zhang ZW, Zhou XJ, Yang L, Zhao JY, Yao JM, Liu M, Liao L: Autologous bone marrow stem cell transplantation in critical limb ischemia: a meta-analysis of randomized controlled trials. Chin Med J (Engl), 2012; 125: 4296-4300
49. Teraa M, Sprengers RW, van der Graaf Y, Peters CE, Moll FL, Verhaar MC: Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials. Ann Surg, 2013; 258: 922-999.